These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 26175568)

  • 21. Value of early cardiovascular magnetic resonance for the prediction of adverse arrhythmic cardiac events after a first noncomplicated ST-segment-elevation myocardial infarction.
    Izquierdo M; Ruiz-Granell R; Bonanad C; Chaustre F; Gomez C; Ferrero A; Lopez-Lereu P; Monmeneu JV; Nuñez J; Chorro FJ; Bodi V
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):755-61. PubMed ID: 23926195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac magnetic resonance imaging as a prognostic tool in patients with nonischemic cardiomyopathy.
    Partington SL; Seabra LF; Kwong RY
    Hosp Pract (1995); 2010 Nov; 38(4):75-82. PubMed ID: 21068530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Right Ventricular Ejection Fraction Is Incremental to Left Ventricular Ejection Fraction for the Prediction of Future Arrhythmic Events in Patients With Systolic Dysfunction.
    Mikami Y; Jolly U; Heydari B; Peng M; Almehmadi F; Zahrani M; Bokhari M; Stirrat J; Lydell CP; Howarth AG; Yee R; White JA
    Circ Arrhythm Electrophysiol; 2017 Jan; 10(1):. PubMed ID: 28087564
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infarct characterization and quantification by delayed enhancement cardiac magnetic resonance imaging is a powerful independent and incremental predictor of mortality in patients with advanced ischemic cardiomyopathy.
    Kwon DH; Asamoto L; Popovic ZB; Kusunose K; Robinson M; Desai M; Marwick TH; Flamm SD
    Circ Cardiovasc Imaging; 2014 Sep; 7(5):796-804. PubMed ID: 25085923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Image-based left ventricular shape analysis for sudden cardiac death risk stratification.
    Vadakkumpadan F; Trayanova N; Wu KC
    Heart Rhythm; 2014 Oct; 11(10):1693-700. PubMed ID: 24854217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advanced imaging for risk stratification for ventricular arrhythmias and sudden cardiac death.
    Xie E; Sung E; Saad E; Trayanova N; Wu KC; Chrispin J
    Front Cardiovasc Med; 2022; 9():884767. PubMed ID: 36072882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator.
    Roes SD; Borleffs CJ; van der Geest RJ; Westenberg JJ; Marsan NA; Kaandorp TA; Reiber JH; Zeppenfeld K; Lamb HJ; de Roos A; Schalij MJ; Bax JJ
    Circ Cardiovasc Imaging; 2009 May; 2(3):183-90. PubMed ID: 19808591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Peri-Infarct Quantification by Cardiac Magnetic Resonance to Predict Outcomes in Ischemic Cardiomyopathy: Prognostic Systematic Review and Meta-Analysis.
    Haghbayan H; Lougheed N; Deva DP; Chan KKW; Lima JAC; Yan AT
    Circ Cardiovasc Imaging; 2019 Nov; 12(11):e009156. PubMed ID: 31735067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility of Cardiac Magnetic Resonance Wideband Protocol in Patients With Implantable Cardioverter Defibrillators and Its Utility for Defining Scar.
    Singh A; Kawaji K; Goyal N; Nazir NT; Beaser A; O'Keefe-Baker V; Addetia K; Tung R; Hu P; Mor-Avi V; Patel AR
    Am J Cardiol; 2019 Apr; 123(8):1329-1335. PubMed ID: 30739658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Denervated Myocardium Is Preferentially Associated With Sudden Cardiac Arrest in Ischemic Cardiomyopathy: A Pilot Competing Risks Analysis of Cause-Specific Mortality.
    Fallavollita JA; Dare JD; Carter RL; Baldwa S; Canty JM
    Circ Cardiovasc Imaging; 2017 Aug; 10(8):. PubMed ID: 28794139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sudden death risk stratification in non-ischemic dilated cardiomyopathy using old and new tools: a clinical challenge.
    Manolis AS
    Expert Rev Cardiovasc Ther; 2017 Apr; 15(4):315-325. PubMed ID: 28292197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death.
    Iles L; Pfluger H; Lefkovits L; Butler MJ; Kistler PM; Kaye DM; Taylor AJ
    J Am Coll Cardiol; 2011 Feb; 57(7):821-8. PubMed ID: 21310318
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sudden cardiac death in nonischemic cardiomyopathy: Refining risk assessment.
    Zipse MM; Tzou WS
    J Cardiovasc Electrophysiol; 2017 Nov; 28(11):1361-1366. PubMed ID: 28670752
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can QRS scoring predict left ventricular scar and clinical outcomes?
    Rosengarten JA; Scott PA; Chiu OK; Shambrook JS; Curzen NP; Morgan JM
    Europace; 2013 Jul; 15(7):1034-41. PubMed ID: 23493411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multimodality imaging predictors of sudden cardiac death.
    Bandera F; Baghdasaryan L; Mandoli GE; Cameli M
    Heart Fail Rev; 2020 May; 25(3):427-446. PubMed ID: 31792657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The extent of left ventricular scar quantified by late gadolinium enhancement MRI is associated with spontaneous ventricular arrhythmias in patients with coronary artery disease and implantable cardioverter-defibrillators.
    Scott PA; Morgan JM; Carroll N; Murday DC; Roberts PR; Peebles CR; Harden SP; Curzen NP
    Circ Arrhythm Electrophysiol; 2011 Jun; 4(3):324-30. PubMed ID: 21493964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left ventricular scar burden specifies the potential for ventricular arrhythmogenesis: an LGE-CMR study.
    Scott PA; Rosengarten JA; Murday DC; Peebles CR; Harden SP; Curzen NP; Morgan JM
    J Cardiovasc Electrophysiol; 2013 Apr; 24(4):430-6. PubMed ID: 23210601
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of myocardial scar characterization to predict ventricular arrhythmia in cardiac resynchronization therapy.
    Fernández-Armenta J; Berruezo A; Mont L; Sitges M; Andreu D; Silva E; Ortiz-Pérez JT; Tolosana JM; de Caralt TM; Perea RJ; Calvo N; Trucco E; Borràs R; Matas M; Brugada J
    Europace; 2012 Nov; 14(11):1578-86. PubMed ID: 22562658
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CinE caRdiac magneTic resonAnce to predIct veNTricular arrhYthmia (CERTAINTY).
    Krebs J; Mansi T; Delingette H; Lou B; Lima JAC; Tao S; Ciuffo LA; Norgard S; Butcher B; Lee WH; Chamera E; Dickfeld TM; Stillabower M; Marine JE; Weiss RG; Tomaselli GF; Halperin H; Wu KC; Ashikaga H
    Sci Rep; 2021 Nov; 11(1):22683. PubMed ID: 34811411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The value of cardiac magnetic resonance and distribution of late gadolinium enhancement for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy.
    Klopotowski M; Kukula K; Malek LA; Spiewak M; Polanska-Skrzypczyk M; Jamiolkowski J; Dabrowski M; Baranowski R; Klisiewicz A; Kusmierczyk M; Jasinska A; Jarmus E; Kruk M; Ruzyllo W; Witkowski A; Chojnowska L
    J Cardiol; 2016 Jul; 68(1):49-56. PubMed ID: 26363820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.